Latest Insider Transactions at Zynex Inc (ZYXI)
This section provides a real-time view of insider transactions for Zynex Inc (ZYXI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ZYNEX INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ZYNEX INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 08
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,156
-5.19%
|
$12,716
$11.16 P/Share
|
|
Sep 07
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,389
-6.76%
|
$18,057
$13.12 P/Share
|
|
Sep 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.52%
|
-
|
|
Aug 27
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+8.75%
|
-
|
|
Aug 27
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+12.16%
|
-
|
|
Aug 25
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
175
-1.03%
|
$2,275
$13.87 P/Share
|
|
Aug 06
2021
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Direct |
177,320
-1.29%
|
$2,659,800
$15.17 P/Share
|
|
Aug 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-2.55%
|
$6,034
$14.54 P/Share
|
|
Aug 04
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
186
-1.17%
|
$2,604
$14.83 P/Share
|
|
Jul 29
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,642
+2.57%
|
-
|
|
Jul 29
2021
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
4,106
+41.2%
|
-
|
|
Jul 29
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,106
+4.09%
|
-
|
|
Jul 27
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.69%
|
-
|
|
Jul 16
2021
|
Michael D Cress |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+29.63%
|
-
|
|
Jul 16
2021
|
Barry D Michaels |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+29.63%
|
-
|
|
Jul 16
2021
|
Joshua R. Disbrow |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+29.63%
|
-
|
|
Jul 08
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,156
-6.96%
|
$16,184
$14.95 P/Share
|
|
Jun 14
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-34.17%
|
$112,000
$16.15 P/Share
|
|
Jun 11
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-42.27%
|
$240,000
$16.29 P/Share
|
|
Jun 10
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-7.8%
|
$48,000
$16.16 P/Share
|
|
Jun 07
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,314
-6.28%
|
$34,710
$15.75 P/Share
|
|
Jun 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.98%
|
-
|
|
May 05
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
701
+1.24%
|
-
|
|
May 05
2021
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,754
+50.0%
|
-
|
|
May 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
350
-1.01%
|
$4,900
$14.13 P/Share
|
|
May 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,754
+1.72%
|
-
|
|
May 04
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-0.55%
|
$2,618
$14.3 P/Share
|
|
Apr 27
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.33%
|
-
|
|
Apr 14
2021
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
438
-1.39%
|
-
|
|
Apr 14
2021
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
24,759
+22.97%
|
-
|
|
Apr 08
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,156
-3.35%
|
$17,340
$15.25 P/Share
|
|
Mar 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,359
-4.15%
|
$19,026
$14.75 P/Share
|
|
Mar 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.76%
|
-
|
|
Feb 25
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,767
+3.68%
|
-
|
|
Feb 05
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
399
-1.36%
|
$7,581
$19.0 P/Share
|
|
Feb 04
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-0.74%
|
$3,834
$18.16 P/Share
|
|
Jan 27
2021
|
Anna Lucsok CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Jan 22
2021
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-6.47%
|
$7,922
$17.54 P/Share
|
|
Jan 22
2021
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+7.42%
|
-
|
|
Jan 08
2021
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,321
-4.48%
|
$18,494
$14.54 P/Share
|
|
Dec 11
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-1.5%
|
$5,200
$13.04 P/Share
|
|
Dec 07
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
800
-3.04%
|
$10,400
$13.8 P/Share
|
|
Dec 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.73%
|
-
|
|
Nov 30
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Other acquisition or disposition
|
Indirect |
203,401
-7.91%
|
-
|
|
Nov 05
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
2,969
+4.82%
|
-
|
|
Nov 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.56%
|
$1,742
$13.57 P/Share
|
|
Nov 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,157
+4.06%
|
-
|
|
Nov 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-0.68%
|
$2,106
$13.46 P/Share
|
|
Oct 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-7.27%
|
$5,600
$14.24 P/Share
|
|
Oct 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.25%
|
-
|